Index Performance
-1.38%
AIHC
-3.84%
ICEBIOT
-0.73%
SPSIBITR
Overview
Description
The Intelligent Healthcare Select strategy (AIHC) uses OpenAI's ChatGPT, Google's Bard, and Inflection AI's Claude to build a custom weighted portfolio of US-listed stocks in the healthcare sector. The strategy aims to create superior quality-focused returns compared to the MSCI US Investable Market Health Care 25/50 Index.
- TickerAIHC
- Inception Date10/16/2023
- WeightingCustom
- # of holdings128
What's inside?
Holdings
All holdings as of December 5, 2023
CSV download
Intuitive Surgical, Inc. (ISRG) | 8.37% | $108.973B | 11.96% | 66.94% | 14.35x |
DexCom, Inc. (DXCM) | 8.20% | $45.283B | 26.69% | 63.75% | 11.55x |
Edwards Lifesciences Corp. (EW) | 7.97% | $41.758B | 12.27% | 75.71% | 7.07x |
IDEXX Laboratories, Inc. (IDXX) | 6.65% | $43.100B | 8.78% | 59.72% | 10.46x |
Stryker Corp. (SYK) | 5.67% | $110.363B | 9.60% | 61.52% | 5.84x |
Medtronic Plc (MDT) | 4.55% | $104.803B | 5.26% | 60.10% | 3.44x |
Boston Scientific Corp. (BSX) | 3.13% | $80.398B | 11.26% | 61.44% | 6.28x |
Zimmer Biomet Holdings, Inc. (ZBH) | 2.35% | $24.204B | 5.02% | 60.83% | 3.95x |
Eli Lilly & Co. (LLY) | 2.35% | $558.335B | 36.84% | 80.42% | 15.62x |
GE Healthcare Technologies, Inc. (GEHC) | 2.23% | $30.925B | N/A | 39.03% | 2.03x |
ResMed, Inc. (RMD) | 2.10% | $23.674B | 16.00% | 53.30% | 5.28x |
Becton, Dickinson & Co. (BDX) | 2.09% | $67.839B | 6.85% | 33.44% | 4.68x |
Thermo Fisher Scientific, Inc. (TMO) | 1.70% | $189.941B | -0.96% | 40.97% | 5.20x |
Bristol Myers Squibb Co. (BMY) | 1.67% | $102.206B | -2.25% | 56.72% | 3.37x |
UnitedHealth Group, Inc. (UNH) | 1.57% | $508.949B | 14.18% | N/A | 1.51x |
Johnson & Johnson (JNJ) | 1.57% | $381.674B | -10.36% | 69.53% | 4.23x |
Merck & Co., Inc. (MRK) | 1.35% | $269.189B | 5.20% | 70.74% | 4.96x |
AbbVie, Inc. (ABBV) | 1.30% | $255.244B | -5.97% | 68.84% | 5.65x |
Abbott Laboratories (ABT) | 1.23% | $181.158B | -2.56% | 49.63% | 4.45x |
Penumbra, Inc. (PEN) | 1.21% | $8.526B | 26.80% | 64.67% | 9.51x |
Shockwave Medical, Inc. (SWAV) | 1.21% | $6.507B | 41.64% | 86.82% | 11.10x |
Pfizer Inc. (PFE) | 1.19% | $164.254B | -41.55% | 19.87% | 3.02x |
Amgen, Inc. (AMGN) | 1.16% | $144.964B | 4.36% | 73.71% | 6.40x |
Insulet Corp. (PODD) | 1.11% | $13.347B | 26.97% | 68.36% | 8.01x |
Vertex Pharmaceuticals, Inc. (VRTX) | 1.06% | $91.259B | 9.33% | 87.15% | 8.30x |
Zoetis, Inc. (ZTS) | 0.99% | $82.480B | 7.44% | 68.57% | 10.19x |
Danaher Corp. (DHR) | 0.81% | $162.150B | -10.31% | 58.20% | 6.63x |
Hologic, Inc. (HOLX) | 0.76% | $16.623B | -0.84% | 52.27% | 4.30x |
Elevance Health, Inc. (ELV) | 0.70% | $113.262B | 7.29% | N/A | 0.76x |
Gilead Sciences, Inc. (GILD) | 0.66% | $98.462B | 0.59% | 77.75% | 4.08x |
Biogen, Inc. (BIIB) | 0.65% | $33.264B | 6.20% | 67.78% | 4.44x |
AstraZeneca PLC (AZN) | 0.64% | $198.003B | -2.79% | 73.15% | 5.24x |
Illumina, Inc. (ILMN) | 0.64% | $17.747B | 0.36% | 61.13% | 5.16x |
Laboratory Corp. of America Holdings (LH) | 0.63% | $18.425B | -15.23% | 26.02% | 1.71x |
Baxter International, Inc. (BAX) | 0.58% | $18.162B | -1.72% | 36.76% | 2.03x |
CVS Health Corp. (CVS) | 0.57% | $91.395B | 10.63% | 15.26% | 0.44x |
IQVIA Holdings, Inc. (IQV) | 0.57% | $39.112B | 5.26% | 27.21% | 3.30x |
Regeneron Pharmaceuticals, Inc. (REGN) | 0.56% | $87.942B | 14.53% | 83.89% | 6.57x |
Quest Diagnostics, Inc. (DGX) | 0.54% | $15.166B | -7.68% | 31.76% | 2.02x |
Globus Medical, Inc. (GMED) | 0.51% | $5.231B | 50.95% | 61.12% | 4.71x |
Humana, Inc. (HUM) | 0.51% | $61.598B | 15.90% | N/A | 0.70x |
Envista Holdings Corp. (NVST) | 0.46% | $4.062B | 0.03% | 57.71% | 2.21x |
Inspire Medical Systems, Inc. (INSP) | 0.43% | $4.384B | 40.40% | 84.10% | 9.45x |
The Cigna Group (CI) | 0.43% | $75.432B | 8.48% | N/A | 0.61x |
Masimo Corp. (MASI) | 0.43% | $5.359B | -12.82% | 49.03% | 2.65x |
Cardinal Health, Inc. (CAH) | 0.42% | $26.407B | 10.40% | 3.11% | 0.11x |
Agilent Technologies, Inc. (A) | 0.42% | $37.416B | -8.71% | 55.81% | 4.60x |
Incyte Corp. (INCY) | 0.41% | $12.286B | 11.63% | 91.75% | 2.66x |
Cencora, Inc. (ABC) | 0.40% | $40.891B | 12.67% | 2.77% | 0.15x |
Integra LifeSciences Holdings Corp. (IART) | 0.33% | $3.245B | -0.72% | 55.64% | 2.89x |
West Pharmaceutical Services, Inc. (WST) | 0.33% | $25.413B | 8.90% | 38.73% | 9.45x |
Centene Corp. (CNC) | 0.32% | $40.070B | 6.07% | N/A | 0.38x |
HCA Healthcare, Inc. (HCA) | 0.32% | $67.587B | 8.30% | 12.90% | 1.75x |
McKesson Corp. (MCK) | 0.31% | $61.314B | 10.06% | 3.75% | 0.22x |
Teleflex, Inc. (TFX) | 0.31% | $10.694B | 8.68% | 55.99% | 3.57x |
Enovis Corp. (CFX) | 0.31% | $2.660B | 8.78% | 50.06% | 1.99x |
Tandem Diabetes Care, Inc. (TNDM) | 0.30% | $1.380B | -9.25% | 48.35% | 1.65x |
QuidelOrtho Corp. (QDEL) | 0.30% | $4.439B | -5.31% | 42.37% | 2.36x |
Waters Corp. (WAT) | 0.29% | $16.848B | 0.44% | 57.43% | 6.18x |
STERIS Plc (Ireland) (STE) | 0.28% | $19.617B | 11.82% | 44.19% | 4.83x |
Mettler-Toledo International, Inc. (MTD) | 0.27% | $23.459B | -4.40% | 57.43% | 6.72x |
Varex Imaging Corp. (VREX) | 0.27% | $764.235M | -1.73% | 33.60% | 1.39x |
TransMedics Group, Inc. (TMDX) | 0.27% | $2.390B | 158.65% | 61.21% | 9.77x |
The Cooper Cos., Inc. (COO) | 0.27% | $16.605B | 10.29% | 60.56% | 6.26x |
Axogen, Inc. (AXGN) | 0.26% | $298.723M | 11.67% | 80.51% | 1.60x |
AtriCure, Inc. (ATRC) | 0.26% | $1.649B | 18.07% | 74.40% | 5.19x |
Glaukos Corp. (GKOS) | 0.25% | $3.173B | 9.51% | 76.28% | 12.34x |
Omnicell, Inc. (OMCL) | 0.25% | $1.523B | -14.19% | 44.09% | 1.86x |
Align Technology, Inc. (ALGN) | 0.24% | $16.493B | 7.85% | 69.57% | 5.86x |
Integer Holdings Corp. (ITGR) | 0.24% | $2.922B | 18.27% | 23.62% | 2.33x |
CONMED Corp. (CNMD) | 0.23% | $3.335B | 12.40% | 51.66% | 3.60x |
Novo Nordisk A/S (NOVO.B) | 0.22% | $338.644B | 28.89% | 83.46% | 13.38x |
Inari Medical, Inc. (NARI) | 0.22% | $3.579B | 31.35% | 87.64% | 7.48x |
Revvity, Inc. (RVTY) | 0.22% | $11.026B | -5.77% | 55.54% | 5.84x |
Axonics, Inc. (AXNX) | 0.22% | $2.898B | 32.27% | 71.75% | 7.21x |
PROCEPT BioRobotics Corp. (PRCT) | 0.22% | $1.969B | 72.50% | 50.77% | 11.83x |
NovoCure Ltd. (NVCR) | 0.22% | $1.365B | -2.81% | 74.79% | 2.76x |
Outset Medical, Inc. (OM) | 0.21% | $273.615M | 9.37% | 23.57% | 3.43x |
Molina Healthcare, Inc. (MOH) | 0.21% | $21.396B | 7.83% | N/A | 0.64x |
Viatris, Inc. (VTRS) | 0.21% | $11.529B | -2.96% | 42.93% | 1.89x |
Artivion, Inc. (AORT) | 0.21% | $728.613M | 14.34% | 59.61% | 2.72x |
iRhythm Technologies, Inc. (IRTC) | 0.21% | $2.624B | 19.96% | 66.19% | 6.05x |
Silk Road Medical, Inc. (SILK) | 0.21% | $368.814M | 18.89% | 72.88% | 2.79x |
Senseonics Holdings, Inc. (SENS) | 0.20% | $338.100M | 31.91% | 19.22% | 15.92x |
Bio-Techne Corp. (TECH) | 0.19% | $10.182B | 2.70% | 66.87% | 9.99x |
Paragon 28, Inc. (FNA) | 0.19% | $932.870M | 14.73% | 72.37% | 5.04x |
Moderna, Inc. (MRNA) | 0.19% | $29.847B | -44.75% | -35.99% | 3.66x |
LivaNova Plc (LIVN) | 0.18% | $2.341B | 13.26% | 68.40% | 2.63x |
Surmodics, Inc. (SRDX) | 0.18% | $482.012M | 7.63% | 71.69% | 3.33x |
LeMaitre Vascular, Inc. (LMAT) | 0.18% | $1.202B | 21.48% | 61.76% | 6.17x |
Nevro Corp. (NVRO) | 0.17% | $667.267M | 3.38% | 64.18% | 1.36x |
Butterfly Network, Inc. (BFLY) | 0.17% | $171.662M | -21.39% | 60.84% | 1.74x |
SI-BONE, Inc. (SIBN) | 0.16% | $741.169M | 28.68% | 79.30% | 5.51x |
AngioDynamics, Inc. (ANGO) | 0.16% | $264.183M | -3.51% | 46.31% | 0.78x |
Treace Medical Concepts, Inc. (TMCI) | 0.14% | $551.999M | 23.30% | 80.38% | 4.32x |
ImmunoGen, Inc. (IMGN) | 0.13% | $7.818B | 637.72% | 98.10% | 14.15x |
Orthofix Medical, Inc. (OFIX) | 0.13% | $384.107M | 61.41% | 62.71% | 0.83x |
CRISPR Therapeutics AG (CRSP) | 0.11% | $5.608B | -100.00% | N/A | 12.39x |
Blueprint Medicines Corp. (BPMC) | 0.10% | $4.456B | -14.26% | 82.80% | 14.38x |
Natera, Inc. (NTRA) | 0.09% | $7.002B | 27.38% | 45.10% | 4.65x |
DaVita, Inc. (DVA) | 0.09% | $9.551B | 5.85% | 27.73% | 1.77x |
BridgeBio Pharma, Inc. (BBIO) | 0.08% | $5.497B | 1,110.36% | 52.65% | 582.88x |
Intra-Cellular Therapies, Inc. (ITCI) | 0.08% | $6.047B | 75.56% | 92.76% | 10.78x |
Karuna Therapeutics, Inc. (KRTX) | 0.08% | $7.847B | -100.00% | N/A | 850.78x |
Vaxcyte, Inc. (PCVX) | 0.08% | $5.111B | N/A | N/A | N/A |
Medpace Holdings, Inc. (MEDP) | 0.08% | $8.493B | 28.34% | 25.65% | 4.36x |
Ascendis Pharma A/S (ASND) | 0.07% | $6.036B | 239.47% | 74.74% | 33.65x |
10X Genomics, Inc. (TXG) | 0.07% | $4.721B | 17.22% | 56.08% | 7.78x |
BioMarin Pharmaceutical, Inc. (BMRN) | 0.07% | $17.633B | 19.57% | 76.04% | 7.37x |
Insmed, Inc. (INSM) | 0.07% | $3.931B | 16.75% | 77.28% | 14.87x |
Universal Health Services, Inc. (UHS) | 0.07% | $8.458B | 6.80% | 8.01% | 1.01x |
Halozyme Therapeutics, Inc. (HALO) | 0.07% | $5.271B | 3.38% | 65.21% | 7.90x |
Repligen Corp. (RGEN) | 0.07% | $8.629B | -29.66% | 36.67% | 13.20x |
Bruker Corp. (BRKR) | 0.07% | $9.107B | 16.26% | 51.68% | 3.57x |
Abcam Plc (ABCM) | 0.07% | $5.494B | 2.71% | 67.49% | 8.44x |
Neurocrine Biosciences, Inc. (NBIX) | 0.07% | $11.647B | 28.59% | 96.83% | 5.92x |
Amicus Therapeutics, Inc. (FOLD) | 0.07% | $3.258B | 26.70% | 88.24% | 10.13x |
Alnylam Pharmaceuticals, Inc. (ALNY) | 0.07% | $21.380B | 183.96% | 88.77% | 13.64x |
United Therapeutics Corp. (UTHR) | 0.07% | $11.293B | 18.10% | 88.50% | 4.15x |
Mirati Therapeutics, Inc. (MRTX) | 0.07% | $3.979B | 201.97% | 84.49% | 49.88x |
Dentsply Sirona, Inc. (XRAY) | 0.07% | $6.818B | N/A | 52.38% | 2.30x |
Alkermes Plc (ALKS) | 0.06% | $4.486B | 50.95% | 80.86% | 2.71x |
Roivant Sciences Ltd. (ROIV) | 0.06% | $7.895B | 196.03% | 78.03% | 81.99x |
ACADIA Pharmaceuticals, Inc. (ACAD) | 0.06% | $3.660B | 61.96% | 93.09% | 4.96x |
Cytokinetics, Inc. (CYTK) | 0.06% | $3.193B | -84.97% | -390.48% | 388.88x |
Bio-Rad Laboratories, Inc. (BIO) | 0.06% | $8.923B | -7.15% | 53.10% | 3.72x |
Organon & Co. (OGN) | 0.04% | $2.835B | -1.17% | 59.71% | 2.06x |
Mural Oncology Plc (MURA) | <0.01% | $62.247M | N/A | N/A | N/A |
Market data by FactSet